In contrast to COX-1, treatment with corticosteroids increased COX-2 expression levels in nasal polyps, suggesting that the inflammatory process affecting the airways in patients with nasal polyps and/or asthma may contribute to downregulating COX-2 [26]. This evidence concerns the gene PTGS1 and nasal cavity polyp.